Analysts at CIBC initiated coverage on shares of SLS International (AMEX:SLS) in a report issued on Thursday. The brokerage set an “outperform” rating on the biotechnology company’s stock.
SLS has been the subject of a number of other reports. Zacks Investment Research raised SLS International from a “hold” rating to a “buy” rating and set a $1.25 price objective for the company in a research report on Friday, August 3rd. Maxim Group cut their price objective on SLS International from $13.00 to $5.00 and set a “buy” rating for the company in a research report on Friday, July 20th. HC Wainwright set a $4.00 price objective on SLS International and gave the stock a “buy” rating in a research report on Tuesday, July 31st. They noted that the move was a valuation call. Finally, Oppenheimer started coverage on SLS International in a research report on Thursday. They set an “outperform” rating and a $13.00 price objective for the company. One analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. SLS International currently has an average rating of “Buy” and an average target price of $5.81.
Shares of SLS remained flat at $$0.00 during midday trading on Thursday.
SLS International Company Profile
SLS international is a language services company which offers translations globally. The Company offers a range of services, including multilingual translations into all Spanish variants, localization, adaptation and content editing. It uses the mother-tongue linguists in order to meet the demanding standards.
See Also: How accurate is the Rule of 72?
Receive News & Ratings for SLS International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SLS International and related companies with MarketBeat.com's FREE daily email newsletter.